"We conduct clinical studies to help develop treatments that make life better for our subjects. We see subjects every day – for everything from acne to HIV – and chances are we’re their last hope. Maybe they’ve already tried everything else, or simply can’t afford treatment. Many people on our team are drawn to clinical research after a friend or family member faced an illness for which no marketed medication was available or adequate. While we always hope studies help our subjects, we fully understand that there may be no benefit to our subject. However, this research may help those who suffer in the future. For us, research isn’t a job or even a career – this is our passion."

During the past decade, Premier Clinical Research conducted 54 clinical trials. In the 10-year time frame, 54 clinical trials started and 59 clinical trials were completed, i.e. on average, 109.3% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 27 clinical trials were completed. i.e. 207.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Premier Clinical Research" #1 sponsor was "Eli Lilly and Company" with 8 trials, followed by "Pfizer" with 7 trials sponsored, "Galderma R&D" with 6 trials sponsored, "LEO Pharma" with 6 trials sponsored and "Gilead Sciences" with 6 trials sponsored. Other sponsors include 59 different institutions and companies that sponsored additional 51 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Premier Clinical Research" #1 collaborator was "Dermira, Inc." with 3 trials as a collaborator, "Acorda Therapeutics" with 1 trials as a collaborator, "Allergan" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Premier Clinical Research" are "Acne Vulgaris" (18 trials), "Atopic Dermatitis" (8 trials), "Actinic Keratosis" (6 trials), "Plaque Psoriasis" (5 trials) and "Hyperhidrosis" (4 trials). Many other conditions were trialed in "Premier Clinical Research" in a lesser frequency.

Most popular intervention types in "Premier Clinical Research" are "Drug" (82 trials), "Other" (15 trials), "Biological" (8 trials), "Device" (8 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (31 trials), "Vehicle" (7 trials), "Lebrikizumab" (5 trials), "BLI1100" (2 trials) and "CB-03-01 cream, 1%" (2 trials). Other intervention names were less common.

The vast majority of trials in "Premier Clinical Research" are 92 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Premier Clinical Research". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 76 completed trials in Premier Clinical Research, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Premier Clinical Research, 2 "Phase 1" clinical trials were conducted, 36 "Phase 2" clinical trials and 43 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 6 trials that are defined as “Not Applicable".